The treatment of tumours expressing somatostatin receptors with yttrium-90 (90Y)-labelled and lutetium-177 (177Lu)-labelled somatostatin analogues is one of the most interesting therapeutic approaches adopted in nuclear medicine in recent years. However, the process of synthesis and fractionation of these radiopharmaceuticals is still mainly carried out manually despite the high radiation exposure to the operators and the need to comply with good manufacturing practices. In this study a semiautomatic synthesizer [automatic dose dispenser (ADD-2)] using only disposable syringes and vials has been presented.
Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials / Asti, Mattia; Atti, Giulia; Iori, Michele; Farioli, Daniela; Filice, Angelina; Versari, Annibale. - In: NUCLEAR MEDICINE COMMUNICATIONS. - ISSN 0143-3636. - STAMPA. - 33:(2012), pp. 1144-1152. [10.1097/MNM.0b013e328358131f]